We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.
- Autoimmune autonomic ganglionopathy
ASJC Scopus subject areas
- Clinical Neurology
- Endocrine and Autonomic Systems